InfuSystem Holdings (INFU) Osake Kurssi

InfuSystem Holdings Inc primarily operates in the healthcare and medical equipment industry.

The main competitors of InfuSystem Holdings Inc in the market include Option Care Health Inc and BioScrip Inc.

InfuSystem Holdings Inc, established in 2005, is a leading provider of infusion pumps and related services in the healthcare industry. With headquarters in Michigan, the company primarily caters to patients and healthcare facilities across the United States and Canada. InfuSystem offers an extensive range of infusion pumps, along with clinical and biomed support, thereby ensuring efficient and cost-effective delivery of medications needed for patient care. Over the years, the company has successfully expanded its product and service portfolio, partnering with medical professionals and hospitals to enhance patient outcomes. InfuSystem Holdings Inc has consistently demonstrated its commitment to revolutionizing healthcare delivery through innovative solutions.

InfuSystem Holdings Inc. has achieved significant milestones since its establishment. Some notable achievements include expanding its presence across the United States, enhancing its product portfolio with innovative offerings, and establishing strategic partnerships. The company has successfully gained a strong reputation for providing high-quality infusion pumps and related services to healthcare facilities and practitioners. InfuSystem Holdings Inc. has also demonstrated consistent growth and financial performance, consolidating its position as a leading provider in the medical device industry. These accomplishments exemplify the company's commitment to delivering excellent products, services, and value to its customers and stakeholders.

InfuSystem Holdings Inc, a leading provider of infusion pumps and related services, primarily operates in the United States. With offices strategically located across the nation, InfuSystem serves healthcare providers in various states and regions. The company focuses on delivering exceptional medical equipment management and infusion therapy services, supporting healthcare professionals and patients in enhancing the quality and ease of care. InfuSystem's strong presence in the United States enables them to maintain close relationships with healthcare institutions, ensuring efficient and reliable delivery of their innovative solutions.

InfuSystem Holdings Inc represents a strong commitment to delivering high-quality, patient-centric healthcare solutions. Their corporate philosophy revolves around providing comprehensive support and innovative technology to healthcare providers. With a focus on enhancing patient care, InfuSystem offers a wide range of infusion pumps, supplies, and services. Through their dedication to exceptional customer service, advanced technology, and improving patient outcomes, InfuSystem Holdings Inc continuously strives to be a reliable partner in the healthcare industry.

Analyytikot asettavat tällä hetkellä InfuSystem Holdings-osakkeelle keskimääräisen tavoitehinnan 15,00 USD (mediaani: 15,00 USD), mikä merkitsee +8,6 % viimeisimpään hintaan verrattuna. Konsensus perustuu 9 analyytikkoarvioon.

InfuSystem Holdings Analyytikkojen kursstavoitteet 2026

9 analyytikkoa arvioi tällä hetkellä InfuSystem Holdings-osaketta: 8 suosittaa ostoa, 1 pitoa ja 0 myyntiä. Vuodelle 2026 analyytikot odottavat InfuSystem Holdings-yhtiöltä 145,16 M USD liikevaihtoa ja 0,47 USD osakekohtaista tulosta.

InfuSystem Holdings Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla InfuSystem Holdings-osake noteerataan hintaan 12,68 EUR (14,13 USD).

InfuSystem Holdings-osake (INFU) on listattuna 2 pörssissä, muun muassa: Frankfurt (1TZ.F).

InfuSystem Holdings Inc is a leading provider of oncology equipment and services. The company offers a wide range of products and services aimed at improving the effectiveness of cancer treatment, improving patient care, and enabling cost savings. The company operates in two main areas: infusion therapy and oncology management. The infusion therapy division includes the rental and sale of infusion pumps and accessories. These pumps are used to administer medications, fluids, and nutrients directly into the patient's bloodstream. InfuSystem offers portable pumps, among other things, that allow patients to conveniently perform their treatment from home. The pumps are equipped with state-of-the-art technology to ensure precise dosing and monitoring of the infusion process. InfuSystem's oncology management program focuses on the management and monitoring of chemotherapy-related side effects, as well as online diagnostics. The program provides close monitoring to ensure that the patient's treatment achieves the best possible results. InfuSystem works closely with treating physicians and nurses to ensure that patients receive the best possible care. In addition to these main activities, InfuSystem also offers a range of complementary products and services, including clinical consulting, education and training, disposable items, and an online platform with comprehensive training materials. These complementary services are designed to improve the effectiveness of cancer treatment and optimize patient care. To deliver its services, InfuSystem has built a network of healthcare customers who support the company as partners in treating their patients. The company's customer base includes a wide range of healthcare facilities, including hospitals, oncology practices, outpatient infusion centers, and other outpatient healthcare providers. Through strategic partnerships and acquisitions, InfuSystem has expanded its reach and ability to provide integrated solutions in the oncology market. Overall, InfuSystem has developed a business model focused on improving cancer treatment, patient care, and cost control. The company offers a wide range of products and services to meet the needs of its healthcare customers and has thus laid a strong foundation for future growth.

odotettu liikevaihto InfuSystem Holdings on 145,16 M USD. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.

odotettu voitto InfuSystem Holdings on 9,99 M USD. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.

InfuSystem Holdings:n hinta-voitto-suhde (P/E) on tällä hetkellä 29,81. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan InfuSystem Holdings-osakkeen arvostusta.

InfuSystem Holdings:n hinta-myynti-suhde (P/S) on tällä hetkellä 2,05. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii InfuSystem Holdings-osakkeen arvostuskennuslukuna.

InfuSystem Holdings:n Eulpool-laatuscore on 5/10.

InfuSystem Holdings:n ISIN on US45685K1025. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

InfuSystem Holdings:n WKN on A0NA9V. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

InfuSystem Holdings:n ticker on INFU. Tämä pörssinoteeraus käytetään InfuSystem Holdings-osakkeiden kauppaan pörssissä.